A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple-Negative Breast Cancer
Interventions: DRUG: Tiragolumab|DRUG: Atezolizumab|DRUG: Nab-paclitaxel|DRUG: Tiragolumab|DRUG: Atezolizumab|DRUG: Nab-paclitaxel|DRUG: Carboplatin|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Granulocyte colony-stimulating factor (G-CSF)|DRUG: Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Sponsor: Hoffmann-La Roche